These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32003362)

  • 1. Lower urinary tract symptoms in patients with advanced prostate cancer: What are the outcomes of androgen deprivation therapy?
    Akpayak IC; Shuaibu SI; Ofoha CG; Dakum NK; Ramyil VM; Onowa VE; Agbo CA; Nabasu LE; Galam ZZ
    Niger Postgrad Med J; 2020; 27(1):49-53. PubMed ID: 32003362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
    Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
    Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.
    Zhang T; Wu H; Liu S; He W; Ding K
    Int Urol Nephrol; 2017 Jul; 49(7):1111-1117. PubMed ID: 28409402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.
    Axcrona K; Aaltomaa S; da Silva CM; Ozen H; Damber JE; Tankó LB; Colli E; Klarskov P
    BJU Int; 2012 Dec; 110(11):1721-8. PubMed ID: 22500884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention.
    Powell T; Staib L; Liu B; Bhatia S; Chai T; Ayyagari R
    Urology; 2021 Oct; 156():216-224. PubMed ID: 33961894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of tamsulosin for treating lower urinary tract symptoms in patients with advanced prostate cancer].
    Govorov AV; Vasilyev AO; Pushkar DY
    Urologiia; 2017 Sep; (4):37-41. PubMed ID: 28952690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Singh DV; Mete UK; Mandal AK; Singh SK
    J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of prostate volume and neoadjuvant androgen-deprivation therapy on urinary function following prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Allen ZA; Lief JH; Hinerman-Mulroy A; Galbreath RW
    Cancer J; 2004; 10(3):181-9. PubMed ID: 15285928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
    Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
    Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study.
    Morote J; Gómez-Caamaño A; de Celis RP; Gómez-Veiga F; Ciria JP; Calleja J; Extramiana J; Pérez-Sampietro M; Perrot V; Angulo JC;
    Neurourol Urodyn; 2022 Nov; 41(8):1824-1833. PubMed ID: 36069170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on lower urinary tract symptoms (LUTS) in elderly patients with prostate cancer (PC) received endocrine therapy.
    Sun S; Bai Y; Yang H; Yang HW
    Arch Gerontol Geriatr; 2015; 60(3):535-7. PubMed ID: 25669858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there any Relationship between Total Prostate Volume, Intravesical Prostatic Protrusion and Lower Urinary Tract Symptoms in Adult Nigerian Men with Benign Prostatic Enlargement?
    Raphael JE; Abhulimen V
    West Afr J Med; 2021 Jun; 38(6):578-582. PubMed ID: 34180211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
    Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
    World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.